Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Passive Dilation Time in Retrograde Intrarenal Surgery

NCT05340088 is registered in ClinicalTrials.gov with Ankara Training and Research Hospital as lead sponsor.

NCT NCT05340088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05340088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Lead sponsor
Ankara Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
September 1, 2021
Completion date
February 1, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stone, kidney, urolithiasis